Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in co-promotion and co-marketing dealmaking



2.1. Introduction

2.2. Difference between co-promotion and co-marketing deals

2.3. Trends in co-promotion deals since 2014

2.3.1. Co-promotion and co-marketing dealmaking by year, 2014 to 2019

2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2014 to 2019

2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2014 to 2019

2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2014 to 2019

2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2014 to 2019

2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2014 to 2019

2.4. When co-marketing can be useful

2.5. When co-marketing is the only option

2.6. Pure deals and multi-component deals

2.6.1. Attributes of pure co-promotion deals

2.6.2. Attributes of co-promotion in multi-component deals

2.7. Reasons for including co-promotion options in a deal

2.8. Uptake of co-promotion rights

2.9. Co-promotion rights as bargaining chips

2.10. Aligning partners to make the co-promote work

2.11. The future of co-promotion as part of multicomponent deals



Chapter 3 – Overview of co-promotion deal structure



3.1. Introduction

3.2. Pure versus multi-component co-promotion deals

3.3. Pure co-promotion agreement structure

3.3.1. Example co-promotion agreements

3.3.1.a. Case study 1: Allergan – MAP Pharmaceuticals

3.3.1.b. Case study 2: Genzyme – Veracyte

3.4. Co-promotion rights as part of a wider alliance agreement

3.4.1. Example co-promotion option clauses

3.4.1.a. Case study 3: Takeda Pharmaceutical– Orexigen Therapeutics

3.4.1.b. Case study 4: Celgene – Acceleron Pharma

3.4.2. Example co-promotion right clauses

3.4.2.a. Case study 5: Takeda – Orexigen

3.4.2.b. Case study 6: Abbvie – Receptos

3.5. Embedded co-promotion rights enabling third party engagement

3.5.1. Example co-promotion clauses enabling third party engagement

3.5.1.a. Case study 7: Astellas – Ambit Biosciences



Chapter 4 – Overview of co-marketing deal structure



4.1. Introduction

4.2. Co-marketing agreement structure

4.2.1. Example co-marketing agreements

4.2.1.a. Case study 8: AstraZeneca –Ironwood Pharmaceuticals

4.3. Co-marketing rights as part of a wider alliance agreement

4.3.1. Example co-marketing right clauses

4.3.1.a. Case study 9: Lundbeck – Myriad Genetics



Chapter 5 – Leading co-promotion and co-marketing deals



5.1. Introduction

5.2. Top co-promotion and co-marketing deals by value



Chapter 6 – Top 25 most active co-promotion and co-marketing dealmakers



6.1. Introduction

6.2. Top 25 most active co-promotion and co-marketing dealmakers



Chapter 7 – Co-promotion and co-marketing agreement contracts directory 2014- 2019



7.1. Introduction

7.2. Co-promotion and co-marketing deals with contracts 2014 to 2019



Appendices



Appendix 1 – Co-promotion and co-marketing deals by company A-Z

Appendix 2 – Co-promotion and co-marketing deals by stage of development

Appendix 3 – Co-promotion and co-marketing deals by deal type

Appendix 4 – Co-promotion and co-marketing deals by therapy area

Appendix 5 – Co-promotion and co-marketing deals by technology type

Appendix 6 –Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from Current Partnering



TABLE OF FIGURES



Figure 1: Definition of co-promotion and co-marketing

Figure 2: Trends in co-promotion and co-marketing deal announcements, 2014 to 2019

Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2014 to 2019

Figure 4: Co-promotion and co-marketing deals by industry sector, 2014 to 2019

Figure 5: Co-promotion and co-marketing deals by therapy area, 2014 to 2019

Figure 6: Co-promotion and co-marketing deals by technology type, 2014 to 2019

Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2014 to 2019

Figure 8: Situations where co-marketing can prove useful

Figure 9: Key components of a pure co-promotion deal

Figure 10: Key components of a multi-component co-promotion deal

Figure 11: Example deals where co-promotion options have been actively exercised, since 2000

Figure 12: Issues in implementing co-promotion agreements

Figure 13: Co-promotion agreements – what should a contract include?

Figure 14: Components of the co-promotion deal structure

Figure 15: Components of the co-marketing deal structure

Figure 16: Top co-promotion and co-marketing deals by value since 2014

Figure 17: Most active co-promotion and co-marketing dealmakers 2014 to 2019

10X Genomics, Abaxis, Abbvie, Abveris, Accinov, Accuray, ACEA Biosciences, Acerus, AC Immune, Advaita, Advanced Analytical Technologies, Advanced Cell Diagnostics, AEterna Zentaris, Affibody, Agena Bioscience, Agilent Technologies, Agios Pharmaceuticals, AGTC, AiLife Diagnostics, AirXpanders, Ajinomoto, Albany Molecular Research, Alector, Alexion Pharmaceuticals, Allegis Holdings, Allergan, Almirall, Alnylam Pharmaceuticals, Alphaeon, Amarin, Amgen, AmpTec, AMRA, Andrew Alliance, Appistry, Applied DNA Sciences, Applied Spectral Imaging, Aratana Therapeutics, ArcherDX, Arcis Biotechnology, Arcturus Therapeutics, Ardelyx, argenx, Aries Pharmaceuticals, Arkema, Armune Bioscience, ArQule, Asahi Kasei, Ascend Therapeutics, Astellas Pharma, AstraZeneca, Automated Systems of Tacoma, Aytu BioScience, Aziyo Biologics, Basilea Pharmaceutica, Bausch & Lomb, Baxalta, Bayer, BD Biosciences, Belintra, Berlin Chemie, BGI Americas, Biochrom, Biocrates, Biodextris, BioDiscovery, Biogen, Biognosys, Biological Industries, BioNano Genomics, BioNTech, BioTek Instruments, Bioverativ, Blake Insomnia Therapeutics, Bluebird Bio, Boehringer Ingelheim, BrainLAB, Bristol-Myers Squibb, Bruker, Cambrooke Therapeutics, Cardiome Pharma, Catalent Pharma Solutions, Celgene, Cellectricon, Cellenion, Cellular Dynamics International, Cellular Research, Centogene, Cevec Pharmaceuticals, Charleston Laboratories, Chromocell, Cisbio Bioassays, Clarify Medical, Clearbridge Biomedics, ClinicalRM, CloudHealth Genomics, COBO Technologies, CompleWare, Concordia Pharmaceuticals, Consortia Health, CorTechs Labs, CRISPR Therapeutics, CrossBay Medical, Crown Bioscience, Cumberland Pharmaceuticals, CureVac, Curio Genomics, Cypher Genomics, Cytokinetics, CytomX Therapeutics, CytoSorbents, Daiichi Sankyo, DARA BioSciences, Denali Therapeutics, DePuy, Diabetes Tools, DirectView Security Systems, Domainex, Dova Pharmaceuticals, Dovetail Genomics, Dynavax Technologies, Eagle Genomics, Eagle Pharmaceuticals, EA Pharma, EarlySense, Egalet, Eigen, Eisai, Elanco, Elekta, Eli Lilly, Elucidata, EMD Serono, Empatica, Entellus Medical, Enterome Bioscience, EOS Imaging, Epicypher, Epizyme, EPS International, Eurofins Genomics, Everledger, Evosep, Exact Sciences, Fate Therapeutics, FlowJo, Fresenius Medical Care, FUJIFILM SonoSite, Galapagos, GE Healthcare, GenDx, Genentech, Genmab, Genomoncology, Genoox, Genzyme, George Clinical, Geron, Gilead Sciences, Gilson, GlaxoSmithKline, Glenmark Pharmaceuticals, Goldfinch Bio, Greiner Bio-One, H3 Biomedicine, HalioDx, Halyard Health, Hanmi Pharmaceutical, Harbour Antibodies, HarkerBIO, HD Biosciences, HeartGenetics, Helsinn Therapeutics, Hepregen, Herman Miller-Nemschoff, Hitachi Medical Systems Europe, Human Longevity, Iagnosis, IBA, Icagen, Iconic Therapeutics, Illumina, Immatics Biotechnologies, ImmunoGen, Immunomedics, Incyte, Innara Health, Innate Pharma, Innova Biosciences, Innovent Biologics, Insitro, InSphero, Inspirion Delivery Sciences, Integrated DNA Technologies, IROA Technologies, Ironwood Pharmaceuticals, Janssen Biotech, Janssen Pharmaceuticals, Jointpoint, Joylux, K2M, Kadmon Pharmaceuticals, Kailos Genetics, Konica Minolta, Kowa Pharmaceuticals America, Kyorin Pharmaceutical, Leica Biosystems, LEO Pharma, Lexicon Pharmaceuticals, LI Path, Loxo Oncology, Luqa Pharmaceuticals, Luxcel Biosciences, Macherey-Nagel, Macrogenics, Malvern Instruments, Mazor Robotics, MDxHealth, MedHelp, Medical Enterprises Distribution, Medicines360, MedImmune, Medtronic, Meiji Seika, Menarini, Merck and Co, Merck KGaA, MGC Diagnostics, Microsoft, Midatech, Miltenyi Biotec, Mission Pharmacal, Mitsubishi Chemical, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Molnlycke Health Care, MorphoSys, MSD, Multispan, Myriad Genetics, N-of-One, Nanion, Nano3D Biosciences, NanoString Technologies, NantPharma, Napo Pharmaceuticals, Ncardia, Neurexpert, Newlink Genetics, Newomics, New York Center for Nanomedicine Research, NGM Biopharmaceuticals, Norgenix Pharmaceuticals, Novartis, Noven Pharmaceuticals, Novogene, Nrgene, Nucleai, Nurix, Ohio Clinical Trials Collaborative, Olympus Medical Systems, Ono Pharmaceutical, Orapharma, OraSure Technologies, ORFLO Technologies, Orion, Ortho-Clinical Diagnostics, Otonomy, Otsuka, Oxford BioMedica, Pacific BioScience of California, Pacific Biosciences, PacificGMP, Pacira Pharmaceuticals, Paragon Bioservices, Pfizer, Pharmaceutics International, Phenomenex, Picometrics Technologies, PierianDx, Pieris, Piramal, Pivot Pharmaceuticals, PositiveID, Poxel, Precipio Diagnostics, Precision BioSciences, Predicine, Protea Biosciences, Protean BioDiagnostics, Protein Metrics, Proteos, PSI (Population Services International), Purdue Pharma, PureHoney Technologies, Pure Pharmaceuticals, Qiagen, Radformation, Rainbow Scientific, RainDance Technologies, RayBiotech, RaySearch Laboratories, Reaction Biology, RedHill Biopharma, Regulus Therapeutics, Revolution Medicines, Roche, Roivant Sciences, Rosetta Genomics, Rubicon Genomics, SAFC, Sajo Consulting, Salix Pharmaceuticals, Sangamo BioSciences, Sanofi, Sanofi-Aventis, Santen Pharmaceutical, Sato Pharmaceutical, Sciex, Seattle Genetics, Seracare Life Sciences, Seren Pharmaceuticals, Shimadzu, Shionogi, Silicon Biosystems, Simcere Pharmaceuticals, Sividon Diagnostics, Sorrento Therapeutics, SoTAX, Spectrum Pharmaceuticals, SPI Pharma, SpiroChem, Stryker, STU, Suneva Medical, Sun Pharmaceutical, SurGenTec, Swift Biosciences, Takeda Pharmaceutical, Tango Therapeutics, Tecan, Teijin, TGR BioSciences, The Fleury Group, Theravance, Thermo Fisher Scientific, Threshold Pharmaceuticals, Tilak Healthcare, Tissue Analytics, TOMI Environmental Solutions, Tracey Technologies, Trovita Health Science, TTP LabTech, UCB, Ultragenyx Pharmaceuticals, Uni-Bio Science, US WorldMeds, Valeant Pharmaceuticals, VCA Antech, Veracyte, Vertex Pharmaceuticals, Vida Diagnostics, ViveBio, Vivid Medical, Waters Corporation, WAVE Life Sciences, White Labs, Wyatt Technology, XCellCure, Xencor, Xoran Technologies, ZAI Laboratory, Ziath, Zymeworks